IRIS PubliCatt

Racioppi, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.453
NA - Nord America 4.300
AS - Asia 1.034
AF - Africa 41
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
Totale 17.871
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.067
US - Stati Uniti d'America 4.234
DE - Germania 1.694
SE - Svezia 846
CN - Cina 557
UA - Ucraina 469
FR - Francia 422
GB - Regno Unito 225
IE - Irlanda 208
SG - Singapore 178
IN - India 171
RU - Federazione Russa 110
FI - Finlandia 98
PL - Polonia 92
CA - Canada 51
CH - Svizzera 51
BE - Belgio 40
TR - Turchia 34
ES - Italia 29
NL - Olanda 24
JP - Giappone 23
CI - Costa d'Avorio 21
BR - Brasile 18
RO - Romania 15
HK - Hong Kong 13
IR - Iran 12
MA - Marocco 12
AT - Austria 10
MX - Messico 10
CZ - Repubblica Ceca 8
GR - Grecia 8
VN - Vietnam 8
KR - Corea 7
EU - Europa 6
IL - Israele 6
AU - Australia 5
ID - Indonesia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
HU - Ungheria 4
MY - Malesia 4
PT - Portogallo 4
TH - Thailandia 4
TW - Taiwan 4
AR - Argentina 3
HR - Croazia 3
IS - Islanda 3
SM - San Marino 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BZ - Belize 2
CO - Colombia 2
CV - Capo Verde 2
EC - Ecuador 2
LK - Sri Lanka 2
LT - Lituania 2
LU - Lussemburgo 2
MD - Moldavia 2
MT - Malta 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CM - Camerun 1
HN - Honduras 1
ME - Montenegro 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
RS - Serbia 1
Totale 17.871
Salva come PNG Salva come JPEG
Città #
Chandler 987
Milan 859
Rome 700
Ashburn 386
Jacksonville 263
Naples 215
San Mateo 205
Dublin 200
Ann Arbor 169
Florence 160
Nanjing 146
Turin 142
Wilmington 138
Singapore 115
Bologna 112
Palermo 103
Dearborn 90
Los Angeles 88
Bremen 85
Nürnberg 85
Kraków 82
New York 79
Nanchang 75
Woodbridge 75
Munich 73
Genoa 71
Lawrence 71
Bari 69
Catania 69
Moscow 67
Redwood City 63
Boston 62
Marseille 62
Verona 62
Houston 55
Beijing 49
Padova 41
Princeton 39
Seattle 39
Lancaster 37
Mountain View 36
Ottawa 36
Brescia 35
Cattolica 34
Perugia 33
Brussels 32
Fairfield 32
Redmond 29
Salerno 28
Venice 28
Bergamo 27
Parma 27
Cagliari 26
Falls Church 26
Reggio Emilia 26
Kunming 25
Pescara 25
Tianjin 25
Livorno 22
Messina 22
Taranto 22
Abidjan 21
Hebei 21
Jiaxing 20
Shenyang 20
University Park 20
Boardman 19
Izmir 19
Augusta 18
Enterprise 18
Trieste 18
Helsinki 17
Lucca 17
Norwalk 16
Changsha 15
Leawood 15
Novara 15
Rimini 15
Hangzhou 14
Caserta 13
Simi Valley 13
Guangzhou 12
Macerata 12
Monza 12
New Delhi 12
Sesto Fiorentino 12
Cambridge 11
Chicago 11
Terni 11
Udine 11
Cesena 10
Changchun 10
Hong Kong 10
Lecce 10
London 10
Madrid 10
Piacenza 10
Portici 10
San Jose 10
São Paulo 10
Totale 7.632
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 6.156
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 914
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 708
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 399
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 296
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 265
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 247
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 245
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 244
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 188
(99m)Tc-MAG3 diuretic renography in diagnosis of obstructive nephropathy in adults: a comparison between F-15 and a new procedure F+10(sp) in seated position 175
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 161
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 160
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 138
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 129
Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence 126
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 123
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 123
The occult urothelial cancer 120
Haemodynamic changes detected during open prostatectomy and transurethral resection for benign prostatic hyperplasia 118
[Overactive bladder syndrome: the social and economic perspective] 117
Endourethral migration of a Hem-o-Lok Clip after robot-assisted laparoscopic radical prostatectomy 117
Male infertility: non-surgical therapy 116
Advanced bladder cancer: New agents and new approaches. A review 113
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 113
Imaging in prostate cancer diagnosis: present role and future perspectives 110
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 110
Hot topics in urological health economics. A mini review 108
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 108
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 108
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 106
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 105
Acid-base and electrolyte balance in urinary intestinal orthotopic reservoir: ileocecal neobladder compared with ileal neobladder 104
Antibiotic prophylaxis in urology 104
Size of Bladder Cancers: Correlation among Different Types of Measurement 103
Behavioural profile and human adaptation of survivors after radical cystectomy and ileal conduit 103
Imaging in prostate cancer staging: present role e future perspectives 102
HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3) 101
NBI: results review 100
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up 100
Imaging of renal cell carcinoma: state of the art and recent advances 96
The Clinical Use of Statistical Permutation Test Methodology: A Tool for Identifying Predictive Variables of Outcome 96
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 95
Imaging in prostate cancer staging: present role and future perspectives 94
Advanced bladder cancer: New agents and new approaches. A review 93
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 92
Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB) 92
Bradeion (SEPT4) as a Urinary Marker of Transitional Cell Bladder Cancer: A Real-Time Polymerase Chain Reaction Study of Gene Expression 92
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 90
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "bCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomes 90
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 89
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 87
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 86
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 86
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 85
Therapeutic strategies in penile cancer: state of the art 85
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study 84
Circumcision: history, religion and law 84
Second-line intravesical therapy. What is the present role of device-assisted therapy? 84
[Innovative treatments of non muscle invasive bladder cancer] 84
Is extracorporeal shock wave lithotripsy in pediatrics a safe procedure? 83
Mitomycin C: new strategies to improve efficacy of a well-known therapy 83
Imaging of renal cell carcinoma: state of the art and recent advances 80
The occult urothelial cancer 80
Bladder and prostate metastasis from small cell lung cancer: a rare entity 79
Therapy for non-muscle invasive bladder cancer: HP-NAP 78
Postoperative nomogram for invasive bladder cancer: Does it really work? A multicenter cohort study 75
Long-term behaviour of secretory immunity in ileocecal and ileal orthotopic neobladders. 73
Imaging in prostate cancer diagnosis: present role and future perspectives 73
Vitamin B12 and folic acid plasma levels after ileocecal and ileal neobladder reconstruction 72
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 72
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients 71
Paclitaxel-hyaluronic acid for intravesical therapy of bacillus Calmette-Guérin refractory carcinoma in situ of the bladder: results of a phase I study. 71
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 70
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study 68
Concordance and clinical significance of uncommon variants of bladder urothelial carcinoma in transurethral resection and radical cystectomy specimens 66
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 66
Meccanismo d'azione del bioconiugato idrosolubile paclitaxel-acido ialuronico su linee cellulari umane di tumore della vescica 65
Patient pad count is a poor measure of urinary incontinence compared with 48-h pad test: results of a large-scale multicentre study 61
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 60
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 60
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 59
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 59
Quality of Life Assessment With Orthotopic Ileal Neobladder Reconstruction After Radical Cystectomy: Results From a Prospective Italian Multicenter Observational Study 58
Imaging of renal cell carcinoma: state of the art and recent advances. 57
Metanephric adenoma with BRAF V600K mutation and a doubtful radiological imaging: pitfalls in the diagnostic process 55
Improved non-invasive diagnosis of bladder cancer with an electronic nose: A large pilot study 55
Artificial urinary sphincter significantly better than fixed sling for moderate post-prostatectomy stress urinary incontinence: a propensity score-matched study 54
Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit 53
Health-Related Quality of Life after Radical Cystectomy for Bladder Cancer in Elderly Patients with Ileal Orthotopic Neobladder or Ileal Conduit: Results from a Multicentre Cross-Sectional Study Using Validated Questionnaires 52
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer? 51
Quality of life following urinary diversion: Orthotopic ileal neobladder versus ileal conduit. A multicentre study among long-term, female bladder cancer survivors 50
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 49
Second-Line Conservative Device-Assisted Intravesical Treatment in Selected Patients With Recurrent High-Risk Non–Muscle-Invasive Bladder Cancer 49
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 47
Chemoablation with Intensive Intravesical Mitomycin C Treatment: A New Approach for Non-muscle-invasive Bladder Cancer 47
Immediate ileal ureter replacement for ureteral avulsion during ureterescopy 47
The cost of treatment and follow-up of bladder cancer in Italy 46
Quality of life in patients with bladder cancer undergoing ileal conduit: A comparison of women versus men 45
[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives] 44
Totale 17.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.221
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.221
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.090 0 0 67 37 83 115 124 82 186 80 187 129
2020/20211.191 46 118 51 111 161 69 134 43 146 66 181 65
2021/20221.385 136 86 45 104 110 77 56 174 94 81 189 233
2022/20234.082 416 397 268 493 215 396 196 338 441 213 400 309
2023/20245.933 330 583 373 514 407 456 453 575 426 565 559 692
2024/20251.274 580 690 4 0 0 0 0 0 0 0 0 0
Totale 18.017